Collectively, these studies establish IGF2BP2 as a key oncogenic driver in thyroid cancer, however, they have examined PTC and ATC as separate entities without considering the continuous differentiation spectrum that characterizes thyroid tumors. The gene discussed is IGF2BP2; the disease is thyroid cancer.